NP49124 Hepatitis C Medicines

A Contract Award Notice
by NHS SCOTLAND

Source
Find a Tender
Type
Framework (Supply)
Duration
2 year (est.)
Value
£37M
Sector
HEALTH
Published
21 Mar 2024
Delivery
To 21 Mar 2026 (est.)
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 2 buyers and 7 suppliers

2 buyers

3 suppliers

Description

Supply of Hepatitis C Medicines to NHS Scotland.

Lot Division

1 Hepatitis C - Treatment Cost per Medicine

The Authority has awarded this Lot as a single supplier framework per line to one (1) Framework Participant.

Award Criteria
Treatment duration 2.5
Genotype testing 2.5
PRICE 95.0
2 Hepatitis C Medicines - Price submitted based on Volume (unscored)

Supply of Hepatitis C to NHS Scotland to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) Framework Participants. Please note II.2.5) Award criteria is not applicable. This was an unscored Lot.

Award Criteria
PRICE _
3 Hepatitis C Medicines - Price submitted based on Volume (unscored)

Supply of Hepatitis C to NHS Scotland to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) Framework Participants. Please note II.2.5) Award criteria is not applicable. This was an unscored Lot.

Award Criteria
PRICE _

Award Detail

1 Abbvie (Maidenhead)
  • Hepatitis C - Treatment Cost per Medicine
  • Num offers: 3
  • Value: £36,556,080 [share]
  • Awarded to group of suppliers.
2 Gilead Sciences (London)
  • Hepatitis C - Treatment Cost per Medicine
  • Num offers: 3
  • Value: £36,556,080 [share]
  • Awarded to group of suppliers.
3 Merck Sharp & Dohme (Hoddesdon)
  • Hepatitis C - Treatment Cost per Medicine
  • Num offers: 3
  • Value: £36,556,080 [share]
  • Awarded to group of suppliers.
4 Gilead Sciences (London)
  • Hepatitis C Medicines - Price submitted based on Volume (unscored)
  • Num offers: 2
  • Value: £1 [share]
  • Awarded to group of suppliers.
5 Abbvie (Maidenhead)
  • Hepatitis C Medicines - Price submitted based on Volume (unscored)
  • Num offers: 2
  • Value: £1 [share]
  • Awarded to group of suppliers.
6 Abbvie (Maidenhead)
  • Hepatitis C Medicines - Price submitted based on Volume (unscored)
  • Num offers: 2
  • Value: £1 [share]
  • Awarded to group of suppliers.
7 Gilead Sciences (London)
  • Hepatitis C Medicines - Price submitted based on Volume (unscored)
  • Num offers: 2
  • Value: £1 [share]
  • Awarded to group of suppliers.

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Other Information

The estimated value(s) referred to in Section section II.I.7 and Section V.2.4 and within all Lots cover(s) the twenty-four (24) month contract duration and the forty-eight (48) month extension period of the framework agreement. (SC Ref:761578)

Reference

Domains